Startup | January 27, 2022
Botanical Solution Inc. raises $6.1 million in Series A
The company develops sustainable botanical materials for agricultural and pharmaceutical applications
The company develops sustainable botanical materials for agricultural and pharmaceutical applications
The current annual U.S. market for prazosin hydrochloride 1mg, 2mg, 5mg strengths is approximately US $ 54 million, according to IQVIA/IMS Health
In an exclusive interview with Rahul Koul of Indian Chemical News, Priyanka Chigurupati, Executive Director, Granules Pharmaceuticals Inc. USA shared details about the company's performance, R&D initiatives, Capex plan, CSR, and future outlook. Excerpts of the interview:
Both these products will be manufactured at Lupin’s Injectable facility at Nagpur, India
New platform powered by Opentrons expands lab automation to accelerate scientific discovery
Havix is a US based company engaged in the business of developing, manufacturing and supplying of various finished formulations
The acquisition of Pivya is an important step in Alembic’s ability to provide branded pharmaceutical product to the US Healthcare market
Loteprednol Etabonate Ophthalmic Gel, 0.38% is a corticosteroid indicated for the treatment of postoperative inflammation and pain following ocular surgery
Granules India receives 1 observation from USFDA for Chantilly facility
Prucalopride Tablets are indicated for the treatment of chronic idiopathic constipation in adults
Subscribe To Our Newsletter & Stay Updated
